Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options [PDF]
Atypical chronic myeloid leukemia (aCML) is a rare form of myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) overlap disorder characterized by neutrophilic leukocytosis with circulating immature myeloid cells (IMC), frequent hepatosplenomegaly, and
Alessandra Iurlo +3 more
doaj +3 more sources
EE-ACML: Energy-Efficient Adiabatic CMOS/MTJ Logic for CPA-Resistant IoT Devices [PDF]
Internet of Things (IoT) devices have strict energy constraints as they often operate on a battery supply. The cryptographic operations within IoT devices consume substantial energy and are vulnerable to a class of hardware attacks known as side-channel ...
Himanshu Thapliyal, Zachary Kahleifeh
exaly +6 more sources
Comprehensive Analysis of Atypical Chronic Myeloid Leukemia (aCML): Epidemiology, Clinical Features, and Survival Outcomes Based on SEER Database Insights [PDF]
Background: Atypical Chronic Myeloid Leukemia (aCML) is a rare and aggressive myelodysplastic syndrome/myeloproliferative neoplasm. This study aimed to provide a comprehensive understanding of the epidemiology, clinical characteristics, and survival ...
Fan Wang
exaly +4 more sources
CNL and aCML Are Prognostically Distinct: A Large National Cancer Database Analysis [PDF]
Douglas Tremblay, John Mascarenhas
exaly +4 more sources
Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia [PDF]
Background: Atypical chronic myeloid leukemia (aCML) is a rare myelodysplastic/myeloproliferative neoplasm. There is no proven standard of care treatment and the only curative option available is hematopoietic stem cell transplant.
Lyndsey Sandow, Michael Heinrich
doaj +2 more sources
Atypical chronic myeloid leukemia found in a patient with eosinophilia for six years: a case report [PDF]
Background Atypical chronic myeloid leukemia (aCML) is a highly aggressive type of blood cancer that falls under the category of myelodysplastic/myeloproliferative neoplasms (MDS/MPN).
Moqin Jiang +5 more
doaj +2 more sources
Adaptive EEG preprocessing to mitigate electrode shift variability for robust motor imagery classification [PDF]
Electrode placement variability poses a critical challenge in EEG-based motor imagery tasks, often resulting in reduced classification robustness. We present the Adaptive Channel Mixing Layer (ACML), a plug-and-play preprocessing module that dynamically ...
Wenjing Xiong, Lin Ma, Haifeng Li
doaj +2 more sources
A case report of atypical chronic myeloid leukemia with complete hematological and major molecular response to Venetoclax/Azacitidine treatment [PDF]
Atypical Chronic Myeloid Leukemia (aCML), a myeloproliferative neoplasm with poor prognosis, was reclassified as aCML by the ICC classification, and as MDS/MPN with neutrophilia by the WHO 2022 classification.
Hongxia Chen +6 more
doaj +2 more sources
Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine [PDF]
BackgroundAtypical chronic myeloid leukemia (aCML) is a BCR::ABL1 negative myelodysplastic/myeloproliferative neoplasm with poor overall survival.
Lu Liu +4 more
doaj +2 more sources
Resistance to imatinib in a ETV6::PDGFRB rearranged myeloid/lymphoid neoplasm with high-risk mutations: a case report [PDF]
Platelet-derived growth factor receptor beta (PDGFRB)-rearranged myeloid/lymphoid neoplasms (MLNs) are rare hematologic malignancies typically responsive to tyrosine kinase inhibitors (TKIs) such as imatinib.
Lucia Cavelier +3 more
doaj +2 more sources

